Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system
Click Here to Manage Email Alerts
Key takeaways:
- Zimmer Biomet received FDA clearance for its OsseoFit stemless shoulder system for total shoulder replacement.
- The system features an anatomically shaped, stemless implant.
Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance for the OsseoFit stemless shoulder system for total shoulder replacement, according to a company press release.
The OsseoFit stemless shoulder system features a press-fit, fully porous implant designed to match patient anatomy during stemless total shoulder replacement, according to the release.
“The OsseoFit stemless shoulder system combines an anatomically shaped implant which supports bone conservation and is designed for stable initial fixation, with our proprietary OsseoTi porous metal technology for biological fixation,” Brian Hatcher, president of extremities, trauma, craniomaxillofacial and thoracic at Zimmer Biomet. “We are pleased to offer OsseoFit within our robust shoulder portfolio that includes modular, compatible components which provide surgeons with a multitude of options based on patients' unique anatomy while maintaining a small instrument footprint and maximizing workflow efficiency.”
According to the release, the OsseoFit stemless shoulder system will be commercially available in the first quarter of 2025.
Read more about
Click Here to Manage Email Alerts